DOI: 10.1369/jhc.4A6311.2004 Volume 52 (10): 1351-1356, 2004 Copyright ©The Histochemical Society, Inc. Cellular Localization of mRNA Expression of Enzymes Involved in the Formation and Inactivation of Hormonal Steroids in the Mouse Prostate
Oncology and Molecular Endocrinology Research Center, Laval University Medical Center, Québec, Canada, and Laval University, Québec, Canada Correspondence to: Dr. Georges Pelletier, Oncology and Molecular Endocrinology Research Center, Laval University Hospital (CHUL), 2705, Laurier Boulevard, Québec, G1V 4G2, Canada. E-mail: georges.pelletier{at}crchul.ulaval.ca
It is well documented that several tissues, including the prostate, are actively involved in the local formation and inactivation of hormonal steroids. To identify the cell types involved in the formation and inactivation of androgens and estrogens in the ventral lobe prostate, we have localized by in situ hybridization (ISH) a large number of steroidogenic as well as steroid-inactivating enzyme mRNAs in the adult mouse prostate. In parallel studies, we also measured enzyme mRNA levels by quantitative real-time PCR (RT-PCR) in ventral lobe prostates. From the results obtained with quantitative RT-PCR, it appears that, with a few exceptions, the enzyme with low mRNA expression could not be detected by ISH. The following enzymes have been localized by ISH: 17ß-hydroxysteroid dehydrogenase (17ß-HSD) types 1, 2, 3, 4, 7, 8, 9, 10, and 11; 5 -reductase type 2; 5ß reductase type 1; P450 7 hydroxylase; estrogen sulfotransferase type 1; 11ß-HSD types 1 and 2; and UDP-glucuronosyltransferase 1A6. All of these mRNAs are expressed in the epithelial cells of prostatic acini. Several enzyme mRNAs were also localized in stromal cells. Types 1, 7, and 10 17ß-HSD, estrogen sulfotransferase type 1, and 11ß-HSD types 1 and 2 were found only in epithelial cells. The present results indicate that both epithelial and stromal cells in the mouse prostate play a role in local formation and inactivation of hormonal steroids. (J Histochem Cytochem 52:13511356, 2004)
Key Words: steroidogenic enzymes prostate androgens estrogens in situ hybridization
IT IS WELL DOCUMENTED that the concentration of dihydrotestosterone (DHT) in human prostate is decreased by only 50% in men who have had their testicles removed or who have had complete blockage of testicular testosterone secretion following chronic treatment with a luteinizing, hormone-releasing hormone agonist (Labrie et al. 1985a
In recent years, the existence of a local biosynthesis of sex steroids, or intracrinology (Labrie et al. 1988 To define the cell types involved in the local synthesis and degradation of sex steroids in the rodent prostate, we have studied the localization of mRNAs expressing a series of steroidogenic enzymes in the mouse ventral prostate by ISH. For each enzyme, we also measured mRNA levels in mouse ventral prostate using quantitative real-time PCR (RT-PCR).
Animals Fourteen adult male and four female (2630 g) C57BL6 mice were housed under constant temperature (21 ± 1C) and light (lights on from 06 to 20 hr) regimen. The animals received Purina Chow (Ralston-Purina, St Louis, MO) and tap water ad libitum. For histological procedures, four male and four female mice were perfused between 09 and 10 hr, as described below. For RNA preparation, 10 male animals were killed by cervical dislocation. The ventral prostates were rapidly trimmed and snap frozen in liquid nitrogen and stored in a 80C freezer until processed.
Histological Procedures
In Situ Hybridization
The cDNA fragments were obtained by amplification using polymerase chain reaction. ISH with the antisense and sense 35S-labeled cRNA probes was performed as previously described (Givalois et al. 1997 After hybridization, coverslips were removed and slides were rinsed in 2x SSC at room temperature for 30 min. Sections were then digested by RNase A (20 µg/ml in 2x SSC) at 37C for 30 min, rinsed in decreasing concentrations of SSC (2x SSC and 1x SSC) for 30 min at room temperature, washed in 0.5x SSC for 30 min at 37C, followed by 90 min at room temperature in 0.5 x SSC, and finally for 30 min at room temperature in 0.1x SSC. The sections were then dehydrated and coated with liquid photographic emulsion (Kodak-NTB2; diluted 1:1 with water). Slides were exposed for 745 days, developed in a Dektol developer (Kodak, Rochester, NY) for 2 min, and fixed in rapid fixer (Kodak) for 4 min. Thereafter, the sections were rinsed and stained with haematoxylin.
RNA Preparation and Quantification of mRNA Expression Levels
Quantification of mRNA levels was performed using a quantitative RT-PCR method that permits monitoring the efficiency of the PCR amplification process by calculating the efficiency coefficient of corresponding standard curves. The LightCycler Realtime PCR apparatus as well as reagents were from Hoffman-La Roche, Inc. (Nutley, NJ). The reaction was performed using the amount of cDNA corresponding to 30 pg of initial total RNA. Oligoprimer pairs that allow the amplification of
As positive controls, enzyme mRNAs were localized by ISH in tissues known to express the enzyme. For all the enzymes studied, positive data were obtained in at least one tissue excluding the prostate (Table 1). Specific labeling was detected in the prostate for the following enzymes involved in either formation or degradation of hormonal steroids: 17ß-HSD types 1, 2, 3, 4, 7, 8, 9, 10, and 11; P450 7 -hydroxylase; 5 -reductase type 2; 5ß-reductase type 1; estrogen sulfotransferase type 1; 11ß-HSD types 1 and 2, and UDP-glucuronosyltransferase 1A6 (UGT1A6) (Table 1). The enzyme mRNAs have been found to be expressed in epithelial cells of the prostatic acini (Table 1; Figures 13)
. In several cases, stromal cells were also specifically labeled (Figures 13). Types 1, 7, and 10 17ß-HSD, 11ß-HSD types 1 and 2, as well as estrogen sulfotransferase type 1 were only detected in epithelial cells. Several enzymes could not be detected by ISH, even following long exposures (up to 45 days). As shown in Table 1, quantitative RT-PCR data show a wide variation in the expression of the different enzyme mRNAs. In general, it could be observed that when the amount of mRNA copies/µg total RNA was less than 2000, no hybridization could be detected. When the radiolabeled sense probes were used for hybridization in consecutive sections, only weak and diffuse labeling corresponding to background could be detected in all cases (Figures 13).
The present results indicate that several enzymes involved in the biosynthesis and inactivation of hormonal steroids can be localized in the mouse prostate by ISH. All the enzymes that we have been able to detect were expressed in epithelial cells. Several enzymes were also found to be expressed in both epithelial and stromal cells. In mouse prostatic acini, the majority of epithelial cells are luminal cells and very few basal cells are observed. In fact, the ratio of luminal to basal cells is 10:1 (El-Alfy et al. 2000 -reductase type 2 (Eicheler et al. 1994 -reductase type 2 mRNA in the mouse prostate indicates that there is a local conversion of the weak androgen testosterone into the most potent natural androgen, DHT. One cannot conclude, however, that when a hybridization signal cannot be detected in the mouse prostatic tissue, the enzyme mRNA is not expressed. The results obtained by quantitative RT-PCR indicate that with a few exceptions, there is a good correlation between the number of mRNA copies/µg total RNA and the detection of ISH signal, which was absent when the number of copies was below 2000. Each probe that provided negative results in the mouse prostatic tissue was shown to give positive results in at least one other tissue, indicating the effectiveness of each probe in detecting specific mRNAs under our experimental conditions. Altogether, the present results indicate that the failure to obtain an ISH signal for some enzymes is likely due to low levels of expression of those enzyme mRNAs.
With the approach involving the use of frozen sections, we could not localize any enzyme in the walls of blood vessels. In previous studies performed in the paraffin-embedded human prostate, we could detect immunoreactive 17ß-HSD type 5 in endothelial cells of capillaries, veins, and arteries (El-Alfy et al. 1999
From the present results, it clearly appears that the enzymes involved in the biosynthesis (17ß-HSD types 1, 3, and 7; 5
Supported by Genome Canada and Genome Québec.
Received for publication March 15, 2004; accepted May 15, 2004
Eicheler W, Tuohimaa P, Vilja P, Adermann K, Forssmann W-G, Aumuller G (1994) Immunocytochemical localization of human 5 El-Alfy M, Luu-The V, Huang XF, Berger L, Labrie F, Pelletier G (1999) Localization of type 5 17ß-hydroxysteroid dehydrogenase, 3ß-hydroxysteroid dehydrogenase and androgen receptor in the human prostate by in situ hybridization and immunocytochemistry. Endocrinology 140:14811491 El-Alfy M, Pelletier G, Hermo LS, Labrie F (2000) Unique features of the basal cells of human prostate epithelium. Microsc Res Tech 51:436446[CrossRef][Medline] Givalois L, Li S, Pelletier G (1997) Age-related decrease in the hypothalamic CRH mRNA expression is reduced by dehydroepiandrosterone (DHEA) treatment in male and female rats. Mol Brain Res 48:107114[Medline] Labrie C, Bélanger A, Labrie F (1988) Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. Endocrinology 123:14121417 Labrie F (1991) Intracrinology. Mol Cell Endocrinol 78:C113C118[CrossRef][Medline] Labrie F, Bélanger A, Cusan L, Labrie C, Simard J, Luu-The V, Diamond P, et al. (1996) History of LHRH agonists and combination therapy in prostate cancer. Endocr Relat Cancer 3:243278 Labrie F, Dupont A, Bélanger A (1985a) Complete androgen blockade for the treatment of prostate cancer. In DeVita VT, Hellman S, Rosenberg SA, eds. Important Advances in Oncology. Philadelphia, JB Lippincott, 193217 Labrie F, Dupont A, Bélanger A, Giguère M, Lacoursière Y, Emond J, Monfette G, et al. (1985b) Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: a marked improvement in response and survival. J Steroid Biochem 23:833841[Medline] Labrie F, Luu-The V, Labrie C, Belanger A, Simard J, Lin SX, Pelletier G (2003) Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone. Endocr Rev 24:152182 Luu-The V (2001) Analysis and characteristics of multiple types of human 17beta-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 76:143151[CrossRef][Medline] Martel C, Melner MH, Gagné D, Simard J, Labrie F (1994) Widespread tissue distribution of steroid sulfatase, 3ß-hydroxysteroid dehydrogenase/ Miller WL (1988) Molecular biology of steroid hormone synthesis. Endocrine Rev 9:295318 Pelletier G, El-Alfy M (2000) Immunocytochemical localization of estrogen receptors alpha and beta in the human reproductive organs. J Clin Endocrinol and Metab 85:48354840 Pelletier G, Luu-The V, Huang XF, Lapointe H, Labrie F (1998) Localization by in situ hybridization of steroid 5 Pelletier G, Luu-The V, Têtu B, Labrie F (1999) Immonocytochemical localization of type 5 17ß-hydroxysteroid dehydrogenase in human reproductive tissues. J Histochem Cytochem 47:731737 Warrington JA, Nair A, Mahadevappa M, Tsyganskaya M (2000) Comparison of human adult and fetal expression and identification of 535 housekeeping/maintenance genes. Physiol Genomics 2:143147
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||